At the recent Radiological Society of North America annual meeting in Chicago, Volpara Solutions launched VolparaDensity 3.0, the first breast density assessment tool clinically available for use with digital breast tomosynthesis datasets from multiple manufacturers. The system is already in use at Peninsula Diagnostic Imaging in San Mateo and Santa Barbara Women’s Imaging in Santa Barbara, Calif.
VolparaDensity for use with Hologic tomosynthesis systems will be available immediately, and the new version, for use with GE and Siemens tomosynthesis units, will be available in early 2015.
“As tomosynthesis users determine the optimal acquisition mode balancing patient dose and clinical benefit, VolparaDensity can be configured to work with conventional 2D image sets as well as 3D tomosynthesis projection data,” said Ralph Highnam, PhD, Volpara Solutions CEO and chief scientist. “This ensures that every woman will receive consistent breast density scores regardless of whether she has received mammography or tomosynthesis.”
Performed similarly to a traditional mammogram, digital breast tomosynthesis, or 3D mammogram, is a multi-view mammography techniques in which each of the individual tomosynthesis projections acquired is a low dose, 2D projection mammogram. VolparaDensity software has been in clinical use since 2010. Version 3.0 reduces the challenges of visually determining breast density based on a review of tomosynthesis slices and new synthetic 2D images, and provides consistent density assessments based on each patient’s actual breast tissue composition.
Carolina Breast Imaging Specialists in Greenville, NC, recently began using the GE SenoClaire 3D breast tomosynthesis system. “VolparaDensity with 3D breast tomosynthesis brings a powerful new combination to the early detection of breast cancer and allows us to further tailor the screening protocol for each woman based on dose and clinical benefits,” said Bruce F. Schroeder, MD.
For more information, visit Volpara Solutions.
